title: Panniculitis after vaccination against CEA and MUC1 in a patient with pancreatic cancer.
authors.affiliation: Department of Surgical Oncology, Columbia University, New York, NY, USA. hlk2003@columbia.edu <hlk2003@columbia.edu>
authors.forename: Howard L
authors.initials: HL
authors.lastname: Kaufman
authors.forename: Amir
authors.initials: A
authors.lastname: Harandi
authors.forename: Matthew C
authors.initials: MC
authors.lastname: Watson
authors.forename: Eric L
authors.initials: EL
authors.lastname: Carter
authors.forename: Gail
authors.initials: G
authors.lastname: DeRaffele
authors.forename: Mohammad
authors.initials: M
authors.lastname: Shahid
authors.forename: Robert L
authors.initials: RL
authors.lastname: Fine
mesh_terms: D000230:Adenocarcinoma / Q000556:secondary / Q000628:therapy*; D000368:Aged; D019496:Cancer Vaccines / Q000009:adverse effects*; D003131:Combined Modality Therapy; D003937:Diagnosis, Differential; D017809:Fatal Outcome; D006801:Humans; D008113:Liver Neoplasms / Q000556:secondary / Q000628:therapy*; D008297:Male; D018396:Mucin-1 / Q000009:adverse effects; D010190:Pancreatic Neoplasms / Q000473:pathology / Q000628:therapy*; D015434:Panniculitis / Q000139:chemically induced / Q000175:diagnosis*; D010446:Peptide Fragments / Q000009:adverse effects
chemical_list: D019496:Cancer Vaccines; C116055:MUC1 tandem repeat peptide; D018396:Mucin-1; D010446:Peptide Fragments